Benefits of Model-based Drug Development: A Rigorous, Planned Case Study

Russell Reeve, Seth Berry, Wei Xiao, Bradley Ferguson, Marcel Thürk, Rüdiger Goetz. Benefits of Model-based Drug Development: A Rigorous, Planned Case Study. Communications in Statistics - Simulation and Computation, 44(9):2210-2222, 2015. [doi]

@article{ReeveBXFTG15,
  title = {Benefits of Model-based Drug Development: A Rigorous, Planned Case Study},
  author = {Russell Reeve and Seth Berry and Wei Xiao and Bradley Ferguson and Marcel Thürk and Rüdiger Goetz},
  year = {2015},
  doi = {10.1080/03610918.2013.833232},
  url = {http://dx.doi.org/10.1080/03610918.2013.833232},
  researchr = {https://researchr.org/publication/ReeveBXFTG15},
  cites = {0},
  citedby = {0},
  journal = {Communications in Statistics - Simulation and Computation},
  volume = {44},
  number = {9},
  pages = {2210-2222},
}